In a recent market survey, ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts an impressive growth outlook for the platelet-rich plasma (PRP) market. The market valuation reached US$ 370.78 Mn in 2021 and is poised to expand at a 6% CAGR through 2031.
Growth registered in the platelet-rich plasma market is attributable to increasing applications of PRPs in various procedures such as cosmetic, orthopedic, neurological, and maxillofacial treatments. Increasing awareness regarding the advantages of platelet-rich plasma in wound healing and tissue regeneration will further propel sales in the market.
To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1722
PRP is being widely used in cosmetic surgeries aimed at improving facial structure and aesthetics, such as skin texture, and color. In addition, PRP is gaining wide acceptance as a key ingredient used in microneedling, botox treatments, acne scar removal, and laser treatments, which is spurring demand in the market.
Besides this, usage of PRPs in orthopedic treatments is fostering market sales, owing to its cost-effectiveness and negligible side effects. PRPs are increasingly finding application in joint pain treatment, cartilage reconstruction, fracture treatments, and other arthritic treatments.
With rising incidence of cosmetic procedures and sports-related injuries in countries including the U.S, the U.K., and Germany, the market is anticipated to garner significant revenue over the forecast period.
Intensive research and development, coupled with the prevalence of leading market players will further augment platelet-rich plasma market growth, with expansion at 12.4% by volume.
Additionally, growing investments in healthcare infrastructure and increasing disposable income will provide tailwinds to platelet-rich plasma sales in counties such as India, China, Brazil, and South Korea, shaping the demand outlook positively.
Download PDF Brochure of the Report – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1722
Key Takeaways from Platelet Rich Plasma Market Survey
– Based on product type, pure platelet-rich plasma (P-PRP) will dominate the segment, due to advanced wound healing properties and cost-effectiveness.
– Autologous platelet-rich plasma will account for maximum sales in the origin segment, with high applications in treatment of nonhealing ulcers.
– In terms of application, cosmetic procedures, surgical and non-surgical, will dominate the segment.
– The U.S. is projected to lead sales of platelet-rich plasma due to increasing incidence of cosmetic surgeries in the country.
– The U.K. will provide lucrative growth opportunities for leading players with intensive research and development in the country aimed at PRP product innovation.
– Germany will emerge as a profitable market for global and regional players, owing to an influx of patients seeking PRP-based treatments in the country.
– Increasing investments in healthcare infrastructure in India, along with growing awareness regarding advantages of PRP will augment market growth.
– Japan and South Korea will account for 5% of the total market share.
Competitive Landscape
Harvest Technologies Corp., Zimmer Biomet Holdings Inc., Arthrex, Inc., Arteriocyte Medical Systems, Inc., Dr. PRP America, Cesca Therapeutics, Inc., and Regen Lab SA are among the prominent players operating in the global platelet-rich plasma market. As per FMI’s analysis, tier-1 players will account for 15-20% of the total market share.
Top Reports Related
Clinical Chemistry Analyzers Market
Pharmaceutical Drug Delivery Market
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports